Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Alliances
Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture To Latin America 9/19/2014 3:08:29 PM
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million 9/19/2014 6:25:08 AM
Crowdsourcing Collaboration Celebrates “Outside The Box” Applications For The Dow Chemical Company (DOW)’s UCON™ Oil Soluble Pags To Help Address Global Challenges 9/19/2014 9:02:26 AM
Swedish Orphan Biovitrum Expands Haemophilia Development Portfolio - Elects To Include Potentially Longer-Acting Haemophilia A Candidate In Collaboration Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB) 9/19/2014 10:06:29 AM
BioTie Therapies Corp.: Selincro Enters The Market In France 9/19/2014 7:14:52 AM
Sigma-Aldrich Corporation (SIAL), University of Michigan Medical School Establish CRISPR Core Lab Partnership 9/18/2014 8:34:23 AM
Boehringer Ingelheim Corporation Will Pay Up To $600 Million For CureVac GmbH Lung Cancer Vaccine 9/18/2014 6:21:48 AM
Merck KGaA (MKGAF.PK) Wants Bids For Cancer Therapy Partners 9/18/2014 6:50:44 AM
Bulldog Bio, Inc. Offered Exclusive Access To Newest Glycobiology Technology 9/18/2014 2:22:55 PM
MYOS (MYOS) Announces Research Agreement With Human Metabolome Technologies America To Conduct Clinical Metabolomic Studies In Subjects Using Fortetropin® 9/18/2014 2:04:55 PM
Elanco Animal Health, Dow AgroSciences LLC (DOW) Announce Strategic R&D Agreement 9/18/2014 1:15:04 PM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding For Manufacture And Development Of BCX4430 To Treat Hemorrhagic Virus Diseases 9/18/2014 11:20:04 AM
Innovus Pharma Signs Exclusive Marketing Sales And Distribution Agreement With Tramorgan Limited To Market And Distribute Sensum+™ In The United Kingdom 9/18/2014 10:16:46 AM
Spectrum Pharmaceuticals, Inc. (SPPI) Out-Licenses Rights For Greater China To CASI Pharmaceuticals  (ENMD) For Three Of Its Drugs 9/18/2014 10:06:20 AM
Galen Signs Exclusive Deal In Europe 9/18/2014 9:21:57 AM
1234567
//-->